SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-063711
Filing Date
2019-11-14
Accepted
2019-11-14 08:00:33
Documents
3
Period of Report
2019-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-22817_18k.htm 8-K 26945
2 EX-99.1 a19-22817_1ex99d1.htm EX-99.1 291859
3 GRAPHIC g228171mmi001.jpg GRAPHIC 2406
  Complete submission text file 0001104659-19-063711.txt   323361
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38410 | Film No.: 191216384
SIC: 2834 Pharmaceutical Preparations